- Clinicopathologic and biological significance of kallikrein 6 overexpression in human gastric cancer.
Nagahara H, Mimori K, Utsunomiya T, Barnard GF, Ohira M, Hirakawa K, Mori M.
Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6800-6.
- Epidermal growth factor receptor gene is highly conserved in pancreatic cancer cells.
Mimori K, Nagahara H, Barnard GF, Mori M.
Pancreas. 2005 Oct;31(3):299. No abstract available.
- Identification of molecular markers for metastasis-related genes in primary breast cancer cells.
Mimori K, Kataoka A, Yoshinaga K, Ohta M, Sagara Y, Yoshikawa Y, Ohno S, Barnard GF, Mori M.
Clin Exp Metastasis. 2005;22(1):59-67.
- Genomic screens for genes upregulated by demethylation in colorectal cancer: possible usefulness for clinical application.
Ogawa K, Utsunomiya T, Mimori K, Yamashita K, Okamoto M, Tanaka F, Inoue H, Ikeda Y, Saku M, Murayama S, Mori M.
Int J Oncol. 2005 Aug;27(2):417-26.
- Differentially expressed genes in endothelial differentiation.
Ishii H, Mimori K, Mori M, Vecchione A.
DNA Cell Biol. 2005 Jul;24(7):432-7.
- Frag1, a homolog of alternative replication factor C subunits, links replication stress surveillance with apoptosis.
Ishii H, Inageta T, Mimori K, Saito T, Sasaki H, Isobe M, Mori M, Croce CM, Huebner K, Ozawa K, Furukawa Y.
Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9655-60. Epub 2005 Jun 27.
- PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma.
Mandelker DL, Yamashita K, Tokumaru Y, Mimori K, Howard DL, Tanaka Y, Carvalho AL, Jiang WW, Park HL, Kim MS, Osada M, Mori M, Sidransky D.
Cancer Res. 2005 Jun 1;65(11):4963-8.
- Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer.
Ogawa K, Utsunomiya T, Mimori K, Tanaka F, Inoue H, Nagahara H, Murayama S, Mori M.
Clin Cancer Res. 2005 Apr 15;11(8):2889-93.
- Components of DNA damage checkpoint pathway regulate UV exposure-dependent alterations of gene expression of FHIT and WWOX at chromosome fragile sites.
Ishii H, Mimori K, Inageta T, Murakumo Y, Vecchione A, Mori M, Furukawa Y.
Mol Cancer Res. 2005 Mar;3(3):130-8.
- Differential roles of E-type cyclins during transformation of murine E2F-1-deficient cells.
Ishii H, Mimori K, Yoshikawa Y, Mori M, Furukawa Y, Vecchione A.
DNA Cell Biol. 2005 Mar;24(3):173-9.
- Clinicopathologic and prognostic values of apolipoprotein D alterations in hepatocellular carcinoma.
Utsunomiya T, Ogawa K, Yoshinaga K, Ohta M, Yamashita K, Mimori K, Inoue H, Ezaki T, Yoshikawa Y, Mori M.
Int J Cancer. 2005 Aug 10;116(1):105-9.
- Somatic mutations of epidermal growth factor receptor in colorectal carcinoma.
Nagahara H, Mimori K, Ohta M, Utsunomiya T, Inoue H, Barnard GF, Ohira M, Hirakawa K, Mori M.
Clin Cancer Res. 2005 Feb 15;11(4):1368-71.
- Detection of occult cancer cells in peripheral blood and bone marrow by quantitative RT-PCR assay for cytokeratin-7 in breast cancer patients.
Masuda TA, Kataoka A, Ohno S, Murakami S, Mimori K, Utsunomiya T, Inoue H, Tsutsui S, Kinoshita J, Masuda N, Moriyama N, Mori M.
Int J Oncol. 2005 Mar;26(3):721-30.
